Investor
Thyme Care secures $60 million in Series B funding, and Neuspera Medical garners $23 million.
If investment patterns in the first half of 2024 persist, this year could exceed year-end totals seen in 2019 and 2023, according to Rock Health's H1 2024 digital health funding report.
Unseen Capital funds entrepreneurs of early-stage healthcare companies focused on addressing the needs of underserved communities.
The company will use the funds to expand its workforce, including its sales team, in order to broaden its biopharma partnerships.
The funding comes a year after the company announced an expanded relationship with OpenAI to develop a chatbot for healthcare providers built on GPT-4.
It has also received Australia's regulatory approval for its AI solution.
The company will use the investment to expand its reach across the U.S. and develop new technologies.
The company will build a genAI-enabled expert health coach that personalizes behavioral change.
The company partners with employers and health plans, such as Medicaid and Medicare, to provide patients with virtual access to registered dietitians.
Also, insurtech company Huize from China is expanding to Southeast Asia.